Pharmacokinetics and safety of binodenos
β
Richard J. Barrett; Michael J. Lamson; James Johnson; William B. Smith
π
Article
π
2005
π
Springer
π
English
β 181 KB
## Background: Binodenoson, a highly selective agonist of the adenosine a 2a receptor, is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging. this study was designed to assess the single-dose pharmacokinetics, safety, and tolera